Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -265,939 | -201,285 | -131,867 | -64,053 | -193,506 |
| Depreciation Amortization | 4,323 | 3,076 | 2,007 | 981 | 3,786 |
| Accounts receivable | 1,738 | 1,620 | 1,976 | 7,167 | -6,209 |
| Accounts payable and accrued liabilities | -887 | 466 | 1,738 | 7 | -318 |
| Other Working Capital | 7,710 | 9,811 | 6,083 | 5,531 | -10,230 |
| Other Operating Activity | 48,172 | 35,678 | 20,154 | 5,696 | 71,800 |
| Operating Cash Flow | $-204,883 | $-150,634 | $-99,909 | $-44,671 | $-134,677 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,880 | -9,041 | -3,048 | -1,933 | -1,288 |
| Investing Cash Flow | $-11,880 | $-9,041 | $-3,048 | $-1,933 | $-1,288 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 561,721 | 112,345 | 101,989 | 4,183 | 332,110 |
| Financing Cash Flow | $561,721 | $112,345 | $101,989 | $4,183 | $332,110 |
| Beginning Cash Position | 393,716 | 393,716 | 393,716 | 393,716 | 197,571 |
| End Cash Position | 738,674 | 346,386 | 392,748 | 351,295 | 393,716 |
| Net Cash Flow | $344,958 | $-47,330 | $-968 | $-42,421 | $196,145 |
| Free Cash Flow | |||||
| Operating Cash Flow | -204,883 | -150,634 | -99,909 | -44,671 | -134,677 |
| Capital Expenditure | -12,010 | -9,171 | -3,178 | -1,933 | -1,288 |
| Free Cash Flow | -216,893 | -159,805 | -103,087 | -46,604 | -135,965 |